Form 8-K - Current report:
SEC Accession No. 0001558370-22-006121
Filing Date
2022-04-27
Accepted
2022-04-27 16:32:51
Documents
13
Period of Report
2022-04-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20220426x8k.htm   iXBRL 8-K 53089
2 EX-3.1 tmb-20220426xex3d1.htm EX-3.1 386832
  Complete submission text file 0001558370-22-006121.txt   624983

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20220426.xsd EX-101.SCH 3031
4 EX-101.LAB tmb-20220426_lab.xml EX-101.LAB 16020
5 EX-101.PRE tmb-20220426_pre.xml EX-101.PRE 11457
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220426x8k_htm.xml XML 4838
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 22860188
SIC: 2836 Biological Products, (No Diagnostic Substances)